Featured Items
 |
Operating Procedures of the PAHO Revolving Fund, October 2008
Operating Procedures of the Revolving Fund for the Purchase of Vaccines, Syringes, and Other Related Supplies through the Pan American Health Organization. Other versions: Spanish, French, Portuguese. More in PDF »
|
|
|
FINAL STATEMENT by (PAHO/WHO) on Investigation of Serious Adverse Events in Peru Following Receipt of Yellow Fever Vaccine Produced by Bio-Manguinhos, Brazil
This PAHO/WHO statement provides results of the investigation of serious adverse events that occurred in October 2007 following administration of yellow fever vaccine (17DD sub-strain) manufactured by Bio-Manguinhos, Brazil.
A previous PAHO/WHO statement on the reported events was issued on 2 November 2007 and recommended temporary suspension of specific lots of the vaccine.
More in PDF »
|
|
|
Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile
WHO scientific consultation, Geneva, Switzerland, 1–3 October 2007 More in PDF »
|
|
|
Symposium Towards Comprehensive Cervical Cancer Prevention & Control, Mexico City, 12-14 May 2008
The Albert B. Sabin Vaccine Institute in collaboration with the Pan American Health Organization (PAHO) and the US Centers for Disease Control and Prevention (CDC) are undertaking a project to research and review published and unpublished sources of HPV epidemiological data in Latin America.
Sabin Vaccine Institute
|
|
| More Featured Items » |
Contact Us
| FCH-IM/PAHO
525 23rd St. NW
Washington, D.C. 20037
Phone: 202.974.3510
Fax: 202.974.3635
E-mail: FCH-IM |
|
|
